The sample preparation process was carried out using the automated MicroLab STAR system (Hamilton Company, Reno, US)
Mean total body fat loss: Postmenopausal women using hormone therapy: 19.9 percent Premenopausal women: 18.7 percent Perimenopausal women: 18.6 percent Postmenopausal women not using hormone therapy: 15.6 percent The difference is striking
If UTI risk from dehydration concerns you with one, switching to the other is unlikely to make a meaningful difference
Improvement of renal problems: it helps to prevent anemia secondary to kidney alterations
Off-Label Prescribing: Many longevity treatments including metformin, rapamycin, low-dose naltrexone, and daily tadalafil are manufactured in FDA-registered facilities for specific approved conditions but are prescribed off-label within longevity-focused or age-related wellness discussions
This compromises our ability to delineate weight loss directly to actual drug effect